Trial Profile
A prospective 5 years real-world study evaluating long term effects of liraglutide in type 2 diabetic patients with vs without steatosis at baseline
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 18 Oct 2018 New trial record
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes